H Bonkhoff

Summary

Country: Germany

Publications

  1. ncbi [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype]
    H Bonkhoff
    Institut für Pathologie Bonn Duisdorf
    Urologe A 43:836-42. 2004
  2. ncbi [Implications of estrogens and their receptors for the development and progression of prostate cancer]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:461-8. 2005
  3. ncbi [Gleason grading: diagnostic criteria and clinical implications]
    H Bonkhoff
    , Berlin
    Pathologe 26:422-32. 2005
  4. ncbi [Prognostic factors in prostate cancer]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:433-43. 2005
  5. ncbi [Differential diagnosis of prostate cancer: impact of pattern analysis and immunohistochemistry]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:405-21. 2005
  6. ncbi [Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype]
    H Bonkhoff
    , Berlin
    Pathologe 26:453-60. 2005
  7. ncbi Simultaneous tumour-like, atypical basal cell hyperplasia and acinar adenocarcinoma of the prostate: a comparative morphological and genetic approach
    A M Luebke
    Department of Urology, University of Hamburg, Martinistrasse 52, 22081 Hamburg, Germany
    Virchows Arch 446:338-41. 2005
  8. ncbi [New insights into the role of estogens and their receptors in prostate cancer]
    H Bonkhoff
    Gemeinschaftspraxis für Pathologie, Frankfurt M
    Urologe A 42:1594-601. 2003
  9. ncbi [Solid-pseudopapillary tumor of the pancreas in a 9-year-old girl]
    S Meyer
    Klinik fur Kinder und Jugendmedizin, Homburg
    Klin Padiatr 214:316-8. 2002
  10. ncbi Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer
    U Wissenbach
    Institut fur Pharmakologie und Toxikologie, Institut für Humangnetik, und Institut für Pathologie der Universität des Saarlandes, D 66421 Homburg, Germany
    J Biol Chem 276:19461-8. 2001

Collaborators

Detail Information

Publications12

  1. ncbi [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype]
    H Bonkhoff
    Institut für Pathologie Bonn Duisdorf
    Urologe A 43:836-42. 2004
    ..Looking for NE differentiation is recommended in the pathological and clinical evaluation of prostate cancer patients for whom radiation and androgen deprivation are therapeutic options...
  2. ncbi [Implications of estrogens and their receptors for the development and progression of prostate cancer]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:461-8. 2005
    ..These data provide a rational for clinical trials to study the efficiency of antiestrogens in the medical treatment of advanced prostate cancer...
  3. ncbi [Gleason grading: diagnostic criteria and clinical implications]
    H Bonkhoff
    , Berlin
    Pathologe 26:422-32. 2005
    ..Reporting the proportion of Gleason grades 4 and 5 in needle biopsies may be critical in terms of treatment decisions. The present review deals with diagnostic criteria of the Gleason grades and its clinical implications...
  4. ncbi [Prognostic factors in prostate cancer]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:433-43. 2005
    ..This review discusses the methods of sampling and reporting in prostate pathology with an emphasis on well established and new prognostic factors...
  5. ncbi [Differential diagnosis of prostate cancer: impact of pattern analysis and immunohistochemistry]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:405-21. 2005
    ..Finally, a selected panel of markers is useful to classify prostatic stromal lesions. In each case, immunohistochemical findings should be interpreted in context with the various patterns on routine microscopy...
  6. ncbi [Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype]
    H Bonkhoff
    , Berlin
    Pathologe 26:453-60. 2005
    ..Pathological and clinical detection of NE features is recommended for all prostate cancer patients for whom radiation therapy and androgen deprivation is being considered...
  7. ncbi Simultaneous tumour-like, atypical basal cell hyperplasia and acinar adenocarcinoma of the prostate: a comparative morphological and genetic approach
    A M Luebke
    Department of Urology, University of Hamburg, Martinistrasse 52, 22081 Hamburg, Germany
    Virchows Arch 446:338-41. 2005
    ..The pathological findings favoured the diagnosis of an atypical basal cell hyperplasia...
  8. ncbi [New insights into the role of estogens and their receptors in prostate cancer]
    H Bonkhoff
    Gemeinschaftspraxis für Pathologie, Frankfurt M
    Urologe A 42:1594-601. 2003
    ..These data provide a rationale for clinical trials to study the efficiency of antiestrogens in the medical treatment of advanced prostate cancer...
  9. ncbi [Solid-pseudopapillary tumor of the pancreas in a 9-year-old girl]
    S Meyer
    Klinik fur Kinder und Jugendmedizin, Homburg
    Klin Padiatr 214:316-8. 2002
    ..Our case report--like a recently published work by Lange et al.--intends to underline the significance of solid-pseudopapillary tumor in the differential diagnosis of a pancreatic mass...
  10. ncbi Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer
    U Wissenbach
    Institut fur Pharmakologie und Toxikologie, Institut für Humangnetik, und Institut für Pathologie der Universität des Saarlandes, D 66421 Homburg, Germany
    J Biol Chem 276:19461-8. 2001
    ..The human CaT-L channel represents a marker for prostate cancer progression and may serve as a target for therapeutic strategies...
  11. ncbi In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: increased basement membrane gene expression in high-grade and metastatic lesions
    C Pföhler
    Department of Pathology, University of the Saarland, Homburg Saar, Germany
    Prostate 36:143-50. 1998
    ....
  12. ncbi Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas
    H Bonkhoff
    Instiute of Pathology, University of the Saarland, Homburg Saar, Germany
    Prostate 29:261-7. 1996
    ..Steroid 5 alpha-reductase is essential for the intracellular accumulation of dihydrotestosterone (DHT), which mediates androgen effects on target tissue...